What did @journeyto150marthaf actually say?
She described feeling like she wanted to throw up roughly three hours after taking semaglutide, triggered by eating a small piece of granola bar and then trying chicken at Costco. Her conclusion: "This is working for sure." That framing, nausea as proof of efficacy, is the claim worth examining here.
To be fair, she wasn't making a formal medical claim. She was documenting a real experience in real time, which is exactly the kind of content that gets 860K views because it feels relatable. But that same relatability is why the interpretation matters. Millions of people are starting GLP-1 medications and watching these videos to understand what to expect. "It's working" is not the same as "this is expected" or "this is safe."
Does the science back this up?
Nausea is genuinely one of the most common side effects of semaglutide. It's not a myth. But nausea being "proof it's working" is a significant oversimplification that the clinical data does not support.
In the STEP 1 trial (Wilding et al., 2021, NEJM), nausea was reported by 44% of participants on semaglutide 2.4mg versus 16% on placebo. It was most common during dose escalation and typically peaked in the first few weeks. Importantly, participants who experienced nausea did not show meaningfully greater weight loss than those who did not. The weight loss mechanism in semaglutide works primarily through GLP-1 receptor agonism in the hypothalamus and gut, slowing gastric emptying and reducing appetite. Nausea is a side effect of that slowing, not the mechanism of weight loss itself.
A 2023 review by Butsch et al. in Obesity Reviews noted that nausea often diminishes over time without dose adjustment, and that persistent nausea severe enough to limit food intake can actually increase the risk of lean muscle loss rather than fat loss, which is the opposite of a desired outcome.
What did they get wrong (or right)?
She got the basic experience right. Early nausea with semaglutide is real and common. The smell sensitivity she described, "you like the smells," aligns with documented GI hypersensitivity during early GLP-1 treatment. These are not fabricated symptoms.
What she got wrong is the interpretation. Framing nausea as confirmation that the drug is "working" conflates a side effect with a therapeutic effect. This is a meaningful distinction. If a patient believes nausea equals efficacy, they may be reluctant to report it to their provider, avoid dose adjustments, or push through symptoms that warrant medical attention.
Severe or persistent nausea can indicate gastroparesis risk, especially at higher doses. The FDA label for Wegovy specifically instructs patients to contact their provider if nausea is severe or does not go away. Three hours post-dose nausea triggered by a granola bar and chicken is worth mentioning to a prescriber, not celebrating as a sign of success.
- Correct: nausea is a common early side effect
- Correct: food smells and certain textures can be triggering
- Misleading: nausea as confirmation of drug efficacy
- Missing: any guidance to consult a provider about the symptom
What should you actually know?
Nausea on semaglutide is expected but not desirable, and it is not a marker that your dose is optimal or your weight loss will be greater. The drug works whether or not you feel sick.
If you are experiencing nausea this early and this intensely, the standard clinical guidance, per the Wegovy prescribing information and the Obesity Medicine Association, is to eat smaller meals, avoid high-fat or high-sugar foods, eat slowly, and stay upright after eating. If nausea is severe enough to stop you from eating almost anything, that conversation belongs with your prescriber, not just a TikTok comment section.
There is also a compounding note worth making here. A significant portion of people starting semaglutide right now are using compounded versions, not FDA-approved Wegovy or Ozempic. Compounded semaglutide is not equivalent to the brand-name drug in terms of regulatory oversight, and dosing protocols can vary significantly. If your nausea is extreme, your dose source matters to your provider.
The broader takeaway is that GLP-1 side effect content on social media tends to normalize symptoms without contextualizing them. That normalization can delay people from reporting problems that actually need attention.